Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR - Concepedia

Concepedia

Publication | Open Access

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR

DOI Full Paper Access

100

Citations

17

References

2018

Year

K.J. Mason, Juliet N. Barker, Catherine Smith, Philip Hampton, Mark Lunt, Kathleen McElhone, Richard B. Warren, Zenas Z N Yiu, C.E.M. Griffiths, A. David Burden

JAMA Dermatology

Abstract

Clinical trial effectiveness and safety outcomes are not representative of real-world patients in BADBIR patients categorized as ineligible for such trials.

References

	Year	Citations

Page 1